Moolec Science SA (NASDAQ:MLEC) Short Interest Update

Moolec Science SA (NASDAQ:MLECGet Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totaling 20,742 shares, a growth of 128.4% from the May 31st total of 9,082 shares. Approximately 3.6% of the company’s stock are short sold. Based on an average daily volume of 37,357 shares, the days-to-cover ratio is currently 0.6 days.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Moolec Science from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th.

Get Our Latest Analysis on MLEC

Moolec Science Stock Up 6.4%

Shares of MLEC stock traded up $0.49 during trading hours on Monday, reaching $8.09. The company had a trading volume of 6,525 shares, compared to its average volume of 817,005. The company has a market cap of $5.91 million, a price-to-earnings ratio of -0.25 and a beta of 0.28. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.15 and a quick ratio of 0.08. Moolec Science has a 12 month low of $3.08 and a 12 month high of $102.00. The business has a fifty day simple moving average of $7.90 and a 200-day simple moving average of $7.58.

Moolec Science (NASDAQ:MLECGet Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The company had revenue of $2.62 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Moolec Science stock. Citadel Advisors LLC acquired a new position in Moolec Science SA (NASDAQ:MLECFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent filing with the Securities and Exchange Commission. 0.07% of the stock is currently owned by hedge funds and other institutional investors.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

Featured Articles

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.